Filter posts

California Senate Passed Drug Price Reporting & Transparency Bill

This week the California Senate passed a tremendously flawed bill that would hamper the ability …

ICYMI: Drug Pricing Bill Is Bad for Business, Patients

Researchers and biotech leaders continue to discover new cures and treatments that are making a …

Op-Ed from Cancer Patient Warns: Don’t Sacrifice Cures Through Price Transparency

Deborah Goldberg’s op-ed to The Sacramento Bee recounts her three-year battle with colon cancer. She …

California’s Transparency Bill Misses the Mark

Under a pending bill in California, drug companies would be required to disclose confidential and …

BIO Opposes Flawed Maryland House Bill

Patrick Plues, BIO’s Vice President, State Government Affairs, testified before the Maryland House in opposition …